The Fly

Moderna COVID-19 booster shortage causes canceled appointments, WSJ reports

Some US pharmacies and other vaccine providers are only offering the new COVID-19 booster shot from Pfizer (PFE) and BioNTech (BNTX) after a quality problem at a contract manufacturer caused a shortage of Moderna’s (MRNA) new booster shot, Peter Loftus of The Wall Street Journal reports. As a result, some pharmacies and other vaccine sits have canceled or stopped scheduling new appointments for people seeking the Moderna booster shot. A Moderna spokesman said the company anticipates resolving constraint issues in the coming days. Reference Link

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on MRNA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More